Cargando…

Therapeutic Opportunities of GPBAR1 in Cholestatic Diseases

GPBAR1, a transmembrane G protein-coupled receptor for bile acids, is widely expressed in multiple tissues in humans and rodents. In recent years, GPBAR1 has been thought to play an important role in bile homeostasis, metabolism and inflammation. This review specifically focuses on the function of G...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Fangling, Xiao, Xiaolin, Li, Yong, Wu, Hefei, Deng, Xinyu, Jiang, Yinxiao, Zhang, Wenwen, Wang, Jian, Ma, Xiao, Zhao, Yanling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8793736/ https://www.ncbi.nlm.nih.gov/pubmed/35095513 http://dx.doi.org/10.3389/fphar.2021.805269

Ejemplares similares

Tripterygium hypoglaucum (Lévl.) Hutch and Its Main Bioactive Components: Recent Advances in Pharmacological Activity, Pharmacokinetics and Potential Toxicity
por: Zhao, Junqi, et al.
Publicado: (2021)

Flavonoids on diabetic nephropathy: advances and therapeutic opportunities
por: Hu, Qichao, et al.
Publicado: (2021)

Preclinical and clinical evidence for the treatment of non-alcoholic fatty liver disease with soybean: A systematic review and meta-analysis
por: Li, Yubing, et al.
Publicado: (2023)

Paeoniflorin, a Natural Product With Multiple Targets in Liver Diseases—A Mini Review
por: Ma, Xiao, et al.
Publicado: (2020)

Mechanism of Paeoniflorin on ANIT-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology
por: Chen, Lisheng, et al.
Publicado: (2021)

The emerging possibility of the use of geniposide in the treatment of cerebral diseases: a review
por: Zhang, Wenwen, et al.
Publicado: (2021)

Mechanism of Paeoniflorin in the Treatment of Bile Duct Ligation-Induced Cholestatic Liver Injury Using Integrated Metabolomics and Network Pharmacology
por: Wei, Shizhang, et al.
Publicado: (2020)

Comparative Evidence for Intrahepatic Cholestasis of Pregnancy Treatment With Traditional Chinese Medicine Therapy: A Network Meta-Analysis
por: Jiang, Yinxiao, et al.
Publicado: (2021)

Deciphering the toxicity-effect relationship and action patterns of traditional Chinese medicines from a smart data perspective: a comprehensive review
por: Li, Yubing, et al.
Publicado: (2023)

Houttuynia cordata Thunb: An Ethnopharmacological Review
por: Wu, Zhao, et al.
Publicado: (2021)

The G-Protein-Coupled Bile Acid Receptor Gpbar1 (TGR5) Inhibits Gastric Inflammation Through Antagonizing NF-κB Signaling Pathway
por: Guo, Cong, et al.
Publicado: (2015)

Discovery of a Potent and Orally Active Dual GPBAR1/CysLT(1)R Modulator for the Treatment of Metabolic Fatty Liver Disease
por: Fiorucci, Stefano, et al.
Publicado: (2022)

Integrating Network Analysis and Metabolomics to Reveal Mechanism of Huaganjian Decoction in Treatment of Cholestatic Hepatic Injury
por: Dong, Qin, et al.
Publicado: (2022)

Uncovering key molecules and immune landscape in cholestatic liver injury: implications for pathogenesis and drug therapy
por: Song, Shuailing, et al.
Publicado: (2023)

The interaction between cellular senescence and chronic kidney disease as a therapeutic opportunity
por: Zhao, Jing-Li, et al.
Publicado: (2022)

Quercetin 7-rhamnoside protects against alpha-naphthylisothiocyanate (ANIT)-induced in cholestatic hepatitis rats by improving biliary excretion and inhibiting inflammatory responses
por: Jin, Hong-Liu, et al.
Publicado: (2023)

Editorial: Ferroptosis as new therapeutic targets in cancer: From molecular mechanisms to therapeutic opportunities
por: Chen, Jian, et al.
Publicado: (2022)

Ileal Bile Acid Transporter Inhibition for the Treatment of Chronic Constipation, Cholestatic Pruritus, and NASH
por: Al-Dury, Samer, et al.
Publicado: (2018)

Structural basis and molecular mechanism of biased GPBAR signaling in regulating NSCLC cell growth via YAP activity
por: Ma, Lijuan, et al.
Publicado: (2022)

Integrative evidence construction for resveratrol treatment of nonalcoholic fatty liver disease: preclinical and clinical meta-analyses
por: He, Xuan, et al.
Publicado: (2023)

Large Dosage of Chishao in Formulae for Cholestatic Hepatitis: A Systematic Review and Meta-Analysis
por: Ma, Xiao, et al.
Publicado: (2014)

Hepatoprotective Effects of Glycyrrhetinic Acid on Lithocholic Acid-Induced Cholestatic Liver Injury Through Choleretic and Anti-Inflammatory Mechanisms
por: Wang, Qian, et al.
Publicado: (2022)

Astragalus saponins and its main constituents ameliorate ductular reaction and liver fibrosis in a mouse model of DDC-induced cholestatic liver disease
por: Zhang, Linzhang, et al.
Publicado: (2022)

Mechanism and Therapeutic Opportunities of Histone Modifications in Chronic Liver Disease
por: Cai, Qiuyu, et al.
Publicado: (2021)

Paeoniflorin Protects against Acetaminophen-Induced Liver Injury in Mice via JNK Signaling Pathway
por: Deng, Xinyu, et al.
Publicado: (2022)

Patchouli alcohol inhibits GPBAR1-mediated cell proliferation, apoptosis, migration, and invasion in prostate cancer
por: Cai, Jian, et al.
Publicado: (2022)

OR09-05 GPBAR1- Understanding Its Function In The Secretory Endometrium
por: Saad-Naguib, Michael, et al.
Publicado: (2023)

Calcipotriol Inhibits NLRP3 Signal Through YAP1 Activation to Alleviate Cholestatic Liver Injury and Fibrosis
por: Wang, Xiaopeng, et al.
Publicado: (2020)

(E)-7-Ethylidene-lithocholic Acid (7-ELCA) Is a Potent Dual Farnesoid X Receptor (FXR) Antagonist and GPBAR1 Agonist Inhibiting FXR-Induced Gene Expression in Hepatocytes and Stimulating Glucagon-like Peptide-1 Secretion From Enteroendocrine Cells
por: Stefela, Alzbeta, et al.
Publicado: (2021)

Mechanism of Hydrophobic Bile Acid-Induced Hepatocyte Injury and Drug Discovery
por: Wei, Shizhang, et al.
Publicado: (2020)

Effect of Different Ratios of Yinchen and Gancao Decoction on ANIT-Treated Cholestatic Liver Injury in Mice and Its Potential Underlying Mechanism
por: Su, Huizong, et al.
Publicado: (2021)

Challenges and Opportunities for Therapeutic Targeting of Calmodulin Kinase II in Heart
por: Nassal, Drew, et al.
Publicado: (2020)

Possible Role of Adenosine in COVID-19 Pathogenesis and Therapeutic Opportunities
por: Geiger, Jonathan D., et al.
Publicado: (2020)

GPBAR1 is associated with asynchronous bone metastasis and poor prognosis of hepatocellular carcinoma
por: Chen, Nan, et al.
Publicado: (2023)

Role of Higenamine in Heart Diseases: A Mini-Review
por: Wen, Jianxia, et al.
Publicado: (2022)

GPBAR1/TGR5 Mediates Bile Acid-Induced Cytokine Expression in Murine Kupffer Cells
por: Lou, Guiyu, et al.
Publicado: (2014)

Metabolomic Assessment of Acute Cholestatic Injuries Induced by Thioacetamide and by Bile Duct Ligation, and the Protective Effects of Huang-Lian-Jie-Du-Decoction
por: Wei, Dan-Dan, et al.
Publicado: (2018)

Network pharmacology reveals the multiple mechanisms of Xiaochaihu decoction in the treatment of non-alcoholic fatty liver disease
por: Hu, Qichao, et al.
Publicado: (2020)

Accelerating Therapeutics for Opportunities in Medicine: A Paradigm Shift in Drug Discovery
por: Hinkson, Izumi V., et al.
Publicado: (2020)

Combined inhibition of PARP and EZH2 for cancer treatment: Current status, opportunities, and challenges
por: Zhang, Xi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kmk6rjj7qtdjtk21e7t170arfk